Abstract
Sickle Cell Disease (SCD) is one of the most prevalent hematological diseases in the world. Despite the immense progress in molecular knowledge about SCD in last years few therapeutical sources are currently available. Nowadays the treatment is performed mainly with drugs such as hydroxyurea or other fetal hemoglobin inducers and chelating agents. This review summarizes current knowledge about the treatment and the advancements in drug design in order to discover more effective and safe drugs. Patient monitoring methods in SCD are also discussed.
Keywords: Drug discovery, hydroxyurea, patient monitoring, sickle cell, sickle cell treatment, new drugs, fetal hemoglobin, chelating agents, gardos channel, poloxamer 188, gene therapy, stem cell transplant, hemoglobin modifiers, nitric oxide
Cardiovascular & Hematological Agents in Medicinal Chemistry
Title: Advances in Sickle Cell Disease Treatment: from Drug Discovery Until the Patient Monitoring
Volume: 9 Issue: 2
Author(s): Jean Leandro dos Santos, Carolina Lanaro and Chung Man Chin
Affiliation:
Keywords: Drug discovery, hydroxyurea, patient monitoring, sickle cell, sickle cell treatment, new drugs, fetal hemoglobin, chelating agents, gardos channel, poloxamer 188, gene therapy, stem cell transplant, hemoglobin modifiers, nitric oxide
Abstract: Sickle Cell Disease (SCD) is one of the most prevalent hematological diseases in the world. Despite the immense progress in molecular knowledge about SCD in last years few therapeutical sources are currently available. Nowadays the treatment is performed mainly with drugs such as hydroxyurea or other fetal hemoglobin inducers and chelating agents. This review summarizes current knowledge about the treatment and the advancements in drug design in order to discover more effective and safe drugs. Patient monitoring methods in SCD are also discussed.
Export Options
About this article
Cite this article as:
Leandro dos Santos Jean, Lanaro Carolina and Man Chin Chung, Advances in Sickle Cell Disease Treatment: from Drug Discovery Until the Patient Monitoring, Cardiovascular & Hematological Agents in Medicinal Chemistry 2011; 9 (2) . https://dx.doi.org/10.2174/187152511796196506
DOI https://dx.doi.org/10.2174/187152511796196506 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
Call for Papers in Thematic Issues
Medicinal Plants with Beneficial Properties on Diabetes and Hypertension
Diabetes and hypertension are real scourges of the 21st century. It is imperative to act in order to find innovative solutions to this problem. Taking medications such as hypoglycemic and antihypertensive drugs may aggravate certain underlying comorbidities, such as chronic kidney disease and cardiovascular disease. This significant drawback therefore requires ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases
Current Gene Therapy Role of PPAR in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Adrenomedullin in Cardiovascular Disease: A Useful Biomarker, its Pathological Roles and Therapeutic Application
Current Protein & Peptide Science From Mars to Venus: Gender Differences in the Management and Outcomes of Acute Coronary Syndromes
Current Pharmaceutical Design Outlook for Aptamers After Twenty Five Years
Current Topics in Medicinal Chemistry Angiotensin II-Induced Signaling Pathways in Diabetes
Current Diabetes Reviews Carotid Intima Media Thickness and Beyond
Current Drug Targets - Cardiovascular & Hematological Disorders A Review on the Role of Phytosterols: New Insights Into Cardiovascular Risk
Current Pharmaceutical Design Characterizing Blood Pressure, Heart Rate, Physical Activity, Circadian Rhythm and their Response to NOS Inhibitor and Substrate in CHF Rats with Telemetry
Vascular Disease Prevention (Discontinued) Five Markers Capable to Identify Passive Smoking Exposure Associated with Endothelial Dysfunction in Healthy Individuals
Current Hypertension Reviews Health Outcomes Associated with Hormone Therapy in Australian Women
Current Drug Safety Antiatherosclerotic and Cardioprotective Effects of Time-Released Garlic Powder Pills
Current Pharmaceutical Design Vorapaxar, a Protease-Activated Receptor-1 Antagonist, a Double –Edged Sword!
Recent Advances in Cardiovascular Drug Discovery (Discontinued) The Role of Cytochrome P450 in Herb-Drug Interactions
Current Pharmacogenomics Discovery of Anticoagulant Drugs: A Historical Perspective
Current Drug Discovery Technologies Human Platelets Express Authentic CB1 and CB2 Receptors
Current Neurovascular Research Preventing Death from Abdominal Aortic Aneurysm Rupture
Vascular Disease Prevention (Discontinued) Targeting Inhibition of COX-2: A Review of Patents, 2002 - 2006
Recent Patents on Inflammation & Allergy Drug Discovery Sildenafil Improves Vascular Endothelial Structure and Function in Renovascular Hypertension
Current Pharmaceutical Biotechnology Diagnostic and Therapeutic Potentials of microRNAs in Heart Failure
Current Topics in Medicinal Chemistry